17 April 2023 - Fast track designation has the potential to facilitate the development and expedite the US FDA review of ...
13 April 2023 - FDA greenlights advancement of SAB-176 Phase 2b trial and manufacturing approach to address influenza strain change. ...
12 April 2023 - Kala Pharmaceuticals today announced that the US FDA has granted fast track designation for Kala’s human mesenchymal ...
11 April 2023 - RGX-202 is a potential one-time AAV therapeutic for the treatment of Duchenne and includes an optimised transgene ...
6 April 2023 - Enanta Pharmaceuticals today announced that the US FDA has granted fast track designation for EDP-323, Enanta’s ...
4 April 2023 - CaMMouflage Phase 1 trial for CB-011 enrolling patients with relapsed or refractory multiple myeloma at dose level ...
5 April 2023 - SynKIR-110 addresses gaps in treatment options for those with malignant pleural mesothelioma, a rare and aggressive ...
4 April 2023 - Shionogi today announced that the US FDA has granted fast track designation for their investigational COVID-19 ...
30 March 2023 - Renovion announced today that the US FDA has granted fast track designation to ARINA-1 for the prevention ...
29 March 2023 - EpicentRx announced today that the US FDA granted fast track designation to RRx-001, a direct NLRP3 inhibitor ...
21 March 2023 - Prestige Biopharma has received fast track designation from the US FDA for PBP1510 (ulenistamab), in the ...
20 March 2023 - Arrowhead Pharmaceuticals today announced the US FDA has granted fast track designation to ARO-APOC3 for reducing ...
17 March 2023 - Prestige Biopharma said on Thursday that its new pancreatic cancer antibody drug candidate, PBP1510, (ulenistamab), was ...
6 March 2023 - Ikena Oncology today announced that the US FDA has granted fast track designation for IK-175, the ...
21 February 2023 - Icosavax today announced the US FDA has granted fast track designation for IVX-A12, a bivalent respiratory syncytial ...